As of 2024-12-15, the Relative Valuation of Innocan Pharma Corp (INNO.CN) is (0.00) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.21 CAD, the upside of Innocan Pharma Corp based on Relative Valuation is -100.6%.
The range of the Relative Valuation is (0.00) - (0.03) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 1.9x | 0.1x |
| Forward P/E multiples | -3.2x - 1.9x | 0.1x |
| Fair Price | (0.00) - (0.03) | (0.00) |
| Upside | -100.5% - -112.0% | -100.6% |
| Date | P/E |
| 2024-11-22 | -16.19 |
| 2024-11-21 | -16.96 |
| 2024-11-20 | -16.19 |
| 2024-11-19 | -16.19 |
| 2024-11-18 | -16.58 |
| 2024-11-15 | -17.73 |
| 2024-11-14 | -17.35 |
| 2024-11-13 | -16.96 |
| 2024-11-12 | -15.42 |
| 2024-11-11 | -17.73 |
| 2024-11-08 | -15.42 |
| 2024-11-07 | -16.19 |
| 2024-11-06 | -17.73 |
| 2024-11-05 | -17.73 |
| 2024-11-04 | -17.73 |
| 2024-11-01 | -17.73 |
| 2024-10-31 | -17.73 |
| 2024-10-30 | -16.96 |
| 2024-10-29 | -17.73 |
| 2024-10-28 | -17.35 |
| 2024-10-25 | -17.73 |
| 2024-10-24 | -17.35 |
| 2024-10-23 | -16.19 |
| 2024-10-22 | -16.96 |
| 2024-10-21 | -16.96 |
| 2024-10-18 | -16.96 |
| 2024-10-17 | -16.96 |
| 2024-10-16 | -16.96 |
| 2024-10-15 | -16.58 |
| 2024-10-11 | -16.96 |
| 2024-10-10 | -16.96 |
| 2024-10-09 | -16.19 |
| 2024-10-08 | -16.19 |
| 2024-10-07 | -16.58 |
| 2024-10-04 | -16.96 |
| 2024-10-03 | -16.19 |
| 2024-10-02 | -16.96 |
| 2024-10-01 | -16.96 |
| 2024-09-30 | -17.73 |
| 2024-09-27 | -18.50 |
| 2024-09-26 | -18.50 |
| 2024-09-25 | -17.73 |
| 2024-09-24 | -18.50 |
| 2024-09-23 | -18.50 |
| 2024-09-20 | -18.50 |
| 2024-09-19 | -18.50 |
| 2024-09-18 | -18.12 |
| 2024-09-17 | -18.50 |
| 2024-09-16 | -18.50 |
| 2024-09-13 | -18.50 |